A study by Pan developed a simple and highly sensitive method for detecting aldo-ketoreductase family 1 member B10 (AKR1B10) in serum, which is a prognostic marker and therapeutic target for colorectal cancer (CRC). Here, AKR1B10 is linked to colorectal carcinoma.